Krebs Biochemicals And Stock Fundamentals
| KREBSBIO | 109.74 5.60 5.38% |
Krebs Biochemicals and fundamentals help investors to digest information that contributes to Krebs Biochemicals' financial success or failures. It also enables traders to predict the movement of Krebs Stock. The fundamental analysis module provides a way to measure Krebs Biochemicals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Krebs Biochemicals stock.
As of now, Krebs Biochemicals' Income Tax Expense is increasing as compared to previous years. The Krebs Biochemicals' current Selling And Marketing Expenses is estimated to increase to about 48.5 M, while Depreciation And Amortization is projected to decrease to under 51.5 M. Krebs | Select Account or Indicator |
Krebs Biochemicals and Company Profit Margin Analysis
Krebs Biochemicals' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Krebs Biochemicals Profit Margin | (0.37) % |
Most of Krebs Biochemicals' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Krebs Biochemicals and is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Krebs Biochemicals and has a Profit Margin of -0.3711%. This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The profit margin for all India stocks is notably higher than that of the company.
Krebs Biochemicals and Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Krebs Biochemicals's current stock value. Our valuation model uses many indicators to compare Krebs Biochemicals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Krebs Biochemicals competition to find correlations between indicators driving Krebs Biochemicals's intrinsic value. More Info.Krebs Biochemicals and is currently regarded as number one stock in return on asset category among its peers. It also is currently regarded as number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Krebs Biochemicals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Krebs Biochemicals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Krebs Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Krebs Biochemicals' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Krebs Biochemicals could also be used in its relative valuation, which is a method of valuing Krebs Biochemicals by comparing valuation metrics of similar companies.Krebs Biochemicals is currently under evaluation in profit margin category among its peers.
Krebs Fundamentals
| Return On Asset | -0.0532 | ||||
| Profit Margin | (0.37) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 4.18 B | ||||
| Shares Outstanding | 21.56 M | ||||
| Shares Owned By Insiders | 77.55 % | ||||
| Price To Sales | 4.50 X | ||||
| Revenue | 504.21 M | ||||
| Gross Profit | 244.19 M | ||||
| EBITDA | (82.73 M) | ||||
| Net Income | (197.28 M) | ||||
| Cash And Equivalents | (1 K) | ||||
| Total Debt | 2.39 B | ||||
| Book Value Per Share | (55.29) X | ||||
| Cash Flow From Operations | 23.04 M | ||||
| Earnings Per Share | (10.10) X | ||||
| Number Of Employees | 191 | ||||
| Beta | 0.46 | ||||
| Market Capitalization | 2.37 B | ||||
| Total Asset | 1.78 B | ||||
| Retained Earnings | (2.7 B) | ||||
| Working Capital | (443.92 M) | ||||
| Net Asset | 1.78 B |
About Krebs Biochemicals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Krebs Biochemicals and's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Krebs Biochemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Krebs Biochemicals and based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 132.7 M | 121.4 M | |
| Total Revenue | 504.2 M | 274.5 M | |
| Cost Of Revenue | 613 M | 342.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.